activins has been researched along with Scleroderma, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gono, T; Hara, M; Katsumata, Y; Kawaguchi, Y; Kawamoto, M; Ota, Y; Takagi, K; Takagi, M; Tochimoto, A; Yamanaka, H | 1 |
| Bagchi, D; Cerinic, MM; Das, DK; Del Rosso, A; Generini, S; Kalin, R; Righi, A | 1 |
2 other study(ies) available for activins and Scleroderma, Systemic
| Article | Year |
|---|---|
Activation of the activin A-ALK-Smad pathway in systemic sclerosis.
Topics: Activin Receptors, Type I; Activins; Cells, Cultured; Collagen; Fibroblasts; Humans; Nitric Oxide; Scleroderma, Systemic; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta | 2011 |
Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis.
Topics: Activins; Anthocyanins; Cell Adhesion; E-Selectin; Humans; Inflammation; Intercellular Adhesion Molecule-1; Malondialdehyde; Models, Chemical; Oxidative Stress; Pilot Projects; Plant Extracts; Proanthocyanidins; Scleroderma, Systemic; Seeds; Vascular Cell Adhesion Molecule-1; Vitis | 2002 |